Structural model of the BCL-w-BID peptide complex and its interactions with phospholipid micelles

Biochemistry

Volumn 45, Issue 7, 2006, Pages 2250-2256

  Denisov, Alexey Yu ^a   Chen, Gang ^b,c   Sprules, Tara ^a   Moldoveanu, Tudor ^a   Beauparlant, Pierre ^b   Gehring, Kalle ^a  

^a MCGILL UNIVERSITY   (Canada)

^b INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIPIDS; MICELLES; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHOLIPIDS;

ANTIAPOPTOTIC PROTEIN; CONFORMATIONAL REARRANGEMENTS; MOLECULAR DOCKING; PROAPOPTOTIC PROTEIN;

PROTEINS;

BH3 PROTEIN; DODECYLPHOSPHORYLCHOLINE; PHOSPHOLIPID; PROTEIN BCL W; PROTEIN BID;

ALPHA HELIX; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; HUMAN; MICELLE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PROTEIN SECRETION; PROTEIN STRUCTURE;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BCL-X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; COMPUTER SIMULATION; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; MICE; MICELLES; MODELS, MOLECULAR; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDE FRAGMENTS; PHOSPHOLIPIDS; PROTEIN CONFORMATION; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 33144479535     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi052332s     Document Type: Article

References (48)

1. Danial, N. N., and Korsmeyer, S. J. (2004) Cell death: Critical control points, Cell 116, 205-219.
2. Cory, S., Huang, D. C. S., and Adams, J. M. (2003) The Bcl-2 family: Roles in cell survival and oncogenesis, Oncogene 22, 8590-8607.
3. Strasser, A. (2005) The role of BH3-only proteins in the immune system, Nat. Rev. Immunol. 5, 189-200.
4. Kaufmann, T., Schinzel, A., and Borner, C. (2004) Bcl-w(edding) with mithochondria, Trends Cell Biol. 14, 8-12.
5. Chen, L., Willis, A., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., and Huang, D. C. S. (2005) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function, Mol. Cell 17, 393-403.
6. Kuwana, T., Bouchier-Hayes, L., Chipuk, J. E., Bonzon, C., Sullivan, B. A., Green, D. R., and Newmeyer, D. D. (2005) BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly, Mol. Cell 17, 525-535.
7. Pagliari, L. J., Kuwana, T., Bonzon, C., Newmeyer, D. D., Tu, S., Beere, H. M., and Green, D. R. (2005) The multidomain proapoptotic molecules Bax and Bak are directly activated by heat, Proc. Natl. Acad. Sci. U.S.A. 102, 17975-17980.
8. Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., and Green, D. R. (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis, Science 303, 1010-1014.
9. Leu, J. I., Dumont, P., Hafey, M., Murthy, M. E., and George, D. L. (2004) Mitochondrial p53 activates Bak and causes disruption of Bak-Mcl1 complexes, Nat. Cell Biol. 6, 443-450.
10. Petros, A. M., Olejniczak, E. T., and Fesik, S. W. (2004) Structural biology of the Bcl-2 family of proteins, Biochim. Biophys. Acta 1644, 83-94.
11. Muchmore, S. W., Sattler, M., Liang, H., Meadows, R. P., Harlan, J. E., Yoon, H. S., Nettesheim, D., Chang, B. S., Thompson, C. B., Wong, S. L., Ng, S. C., and Fesik, S. W. (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death, Nature 381, 335-341.
12. Aritomi, M., Kunishima, N., Inohara, N., Ishibashi, Y., Ohta, S., and Morikawa, K. (1997) Crystal structure of rat Bcl-xL. Implications for the function of the Bcl-2 protein family, J. Biol. Chem. 272, 27886-27892.
13. Denisov, A. Y., Madiraju, M. S. R., Chen, G., Khadir, A., Beauparlant, P., Attardo, G., Shore, G. C., and Gehring, K. (2003) Solution structure of human BCL-w: Modulation of ligand binding by the C-terminal helix, J. Biol. Chem. 278, 21124-21128.
14. Hinds, M. G., Lackmann, M., Skea, G. L., Harrison, P. J., Huang, D. C. S., and Day, C. L. (2003) The structure of Bcl-w reveal a role for the C-terminal residues in modulating biological activity, EMBO J. 22, 1497-1507.
15. Petros, A. M., Medek, A., Nettesheim, D. G., Kim, D. H., Yoon, H. S., Swift, K., Matayoshi, E. D., Oltersdorf, T., and Fesik, S. W. (2001) Solution structure of the antiapoptotic protein Bcl-2, Proc. Natl. Acad. Sci. U.S.A. 98, 3012-3017.
16. Huang, Q., Petros, A. M., Virgin, H. W., Fesik, S. W., and Olejniczak, E. T. (2002) Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus, Proc. Natl. Acad. Sci. U.S.A. 99, 3428-3433.
17. Day, C. L., Chen, L., Richardson, S. J., Harrison, P. J., Huang, D. C. S., and Hinds, M. G. (2005) Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands, J. Biol. Chem. 280, 4738-4744.
18. Chou, J. J., Li, H., Salvesen, G. S., Yuan, J., and Wagner, G. (1999) Solution structure of BID, an intracellular amplifier of apoptotic signaling, Cell 96, 615-624.
19. McDonnell, J. M., Fushman, D., Milliman, C. L., Korsmeyer, S. J., and Cowburn, D. (1999) Solution structure of the proapoptotic molecule BID: A structural basis for apoptotic agonists and antagonists, Cell 96, 625-634.
20. Suzuki, M., Youle, R. J., and Tjandra, N. (2000) Structure of Bax: Coregulation of dimer formation and intracellular localization, Cell 103, 645-654.
21. Sattler, M., Liang, H., Nettesheim, D., Meadows, R. P., Harlan, J. E., Eberstadt, M., Yoon, H. S., Shuker, S. B., Chang, B. S., Minn, A. J., Thompson, C. B., and Fesik, S. W. (1997) Structure of Bcl-xL-Bak peptide complex: Recognition between regulators of apoptosis, Science 275, 983-986.
22. Petros, A. M., Nettesheim, D. G., Wang, Y., Olejniczak, E. T., Meadows, R. P., Mack, J., Swift, K., Matayoshi, E. D., Zhang, H., Thompson, C. B., and Fesik, S. W. (2000) Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies, Protein Sci. 9, 2528-2534.
23. Liu, X., Dai, S., Zhu, Y., Marrack, P., and Kapper, J. W. (2003) The structure of a Bcl-xL/Bim fragment complex: Implications for Bim function, Immunity 19, 341-352.
24. Losonczi, J. A., Olejniczak, E. T., Betz, S. P., Harlan, J. E., Mack, J., and Fesik, S. W. (2000) NMR studies of the anti-apoptotic protein Bcl-xL in micelles, Biochemistry 39, 11024-11033.
25. Franzin, C. M., Choi, J., Zhai, D., Reed, J. C., and Marassi, F. M. (2004) Structural studies of apoptosis and ion transport regulatory proteins in membranes, Magn. Reson. Chem. 42, 172-179.
26. Gong, X. M., Choi, J., Franzin, C. M., Zhai, D., Reed, J. C., and Marassi, F. M. (2004) Conformation of membrane-associated proapoptotic tBid, J. Biol. Chem. 279, 28954-28960.
27. Liang, H., and Fesik, S. W. (1997) Three-dimensional structures of proteins involved in programmed cell death, J. Mol. Biol. 274, 291-302.
28. Oh, K. J., Barbuto, S., Meyer, N., Kim, R. S., Collier, J., and Korsmeyer, S. J. (2005) Conformational changes in BID, a proapoptotic BCL-2 family member, upon membrane binding, J. Biol. Chem. 280, 753-767.
29. Kim, P. K., Annis, M. G., Dlugosz, P. J., Leber, B., and Andrews, D. W. (2004) During apoptosis Bcl-2 changes membrane topology at both endoplasmic reticulum and mitochondria, Mol. Cell 14, 523-529.
30. Terrones, O., Antonsson, B., Yamaguchi, H., Wang, H. G., Liu, J., Lee, R. M., Hermann, A., and Basanez, G. (2004) Lipid pore formation by the concerted action of proapoptotic BAX and tBID, J. Biol. Chem. 279, 30081-30091.
31. Wilson, J. W., Nostro, M. C., Balzi, M., Faraoni, P., Cianchi, F., Becciolini, A., and Potten, C. S. (2000) Bcl-w expression in colorectal adenocarcinoma, Br. J. Cancer 82, 178-185.
32. Print, C. G., Loveland, K. L., Gibson, L., Meehan, T., Stylianou, A., Wreford, N., de Kretser, D., Metcalf, D., Kontgen, F., Adams, J. M., and Cory, S. (1998) Apoptosis regulator Bcl-w is essential for spermatogenesis but appears otherwise redundant, Proc. Natl. Acad. Sci. U.S.A. 95, 12424-12431.
33. -/- male mice, Cell Death Differ. 8, 225-233.
34. Wilson-Annan, J., O'Reilly, L. A., Crawford, S. A., Hausmann, G., Beaumont, J. G., Parma, L. P., Chen, L., Lackmann, M., Lithgow, T., Hinds, M. G., Day, C. L., Adams, J. M., and Huang, D. C. S. (2003) Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity, J. Cell Biol. 162, 877-887.
35. Cavanagh, J., Fairbrother, W. J., Palmer, A. G., and Skelton, N. J. (1996) Protein NMR Spectroscopy: Principles and Practice, Academic Press, San Diego.
36. Peng, J. W., and Wagner, G. (1994) Investigation of protein motions via relaxation measurements, Methods Enzymol. 239, 563-596.
37. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) NMRpipe: A multidimensional spectral processing system based on UNIX pipes, J. Biomol. NMR 6, 277-293.
38. Bartels, C., Xia, T. H., Billeter, M., Guntert, P., and Wüthrich, K. (1995) The program XEASY for computer-supported NMR spectral analysis of biological macromolecules, J. Biomol. NMR 5, 1-10.
39. Domingues, C., Boelens, R., and Bonvin, A. M. J. J. (2003) HADDOCK: A protein-protein docking approach based on biochemical or biophysical information, J. Am. Chem. Soc. 125, 1731-1737.
40. Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kuntsleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Crystallography and NMR system: A new software suite for macromolecular structure determination, Acta Crystallogr. D54, 905-921.
41. Koradi, R., Billeter, M., and Wüthrich, K. (1996) MOLMOL: A progam for display and analysis of macromolecular structures, J. Mol. Graphics 14, 51-55.
42. Holm, L., and Sander, C. (1993) Protein structure comparison by alignment of distance matrices, J. Mol. Biol. 233, 123-138.
43. Lugovskoy, A. A., Degterev, A. I., Fahmy, A. F., Zhou, P., Gross, J. D., Yuan, J., and Wagner, G. (2002) A novel approach for characterizing protein ligand complexes: Molecular basis for specificity of small-molecule Bcl-2 inhibitors, J. Am. Chem. Soc. 124, 1234-1240.
44. Kitada, S., Leone, M., Sareth, S., Zhai, D., Reed, J. C., and Pellecchia, M. (2003) Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenol targeting B-cell lymphocyte/leukemia-2 proteins, J. Med. Chem. 46, 4259-4264.
45. Yin, H., Lee, G. I., Sedey, K. A., Rodriguez, J. M., Wang, H. G., Sebti, S. M., and Hamilton, A. D. (2005) Terephthalamide derivatives as mimetics of helical peptides: Disruption of the Bcl-x(L)/Bak interaction, J. Am. Chem. Soc. 127, 5463-5468.
46. Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., Joseph, M. K., Kitada, S., Korsmeyer, S. J., Kunzer, A. R., Letai, A., Li, C., Mitten, M. J., Nettesheim, D. G., Ng, S., Nimmer, P. M., O'Connor, J. M., Oleksijew, A., Petros, A. M., Reed, J. C., Shen, W., Tahir, S. K., Thompson, C. B., Tomaselli, K. J., Wang, B., Wendt, M. D., Zhang, H., Fesik, S. W., and Rosenberg, S. H. (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumors, Nature 435, 677-681.
47. Annis, M. G., Soucie, B. L., Dlugosz, P. J., Cruz-Aguado, A., Penn, L. Z., Leber, B., and Andrews, D. W. (2005) Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis, EMBO J. 24, 2096-2103.
48. Jeong, S. Y., Gaume, B., Lee, Y. J., Hsu, Y. T., Ryu, S. W., Yoon, S. H., and Youle, R. J. (2004) Bcl-xL sequesters its C-terminal membrane anchor in soluble, cytosolic homodimers, EMBO J. 23, 2146-2155.